Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CPEB1 antisense RNA 1 (CPEB1-AS1) is a long non-coding RNA (lncRNA) transcribed from the genomic locus opposite the *CPEB1* gene. As an antisense RNA, it is presumed to play a regulatory role in the expression of CPEB1, a gene encoding cytoplasmic polyadenylation element binding protein 1 involved in RNA binding and post-transcriptional gene regulation. There is currently no published evidence that CPEB1-AS1 directly encodes a protein or is a validated therapeutic target such as a receptor, enzyme, or transporter. Its function in human physiology or disease is not well characterized and may be subject to future research. It should not be confused with *CPEB1*, which is a protein with established roles in mRNA regulation[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CPEB1 antisense RNA 1 (CPEB1-AS1).